Mallinckrodt Pharmaceuticals Blog

Kratom.org - Kratom Strains & Vendors Reviewed

Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website

Author: Gena Holthaus

Meet Catherine Jackson, Director of Advocacy Relations

  • by Gena Holthaus
  • Posted on February 11, 2019February 15, 2019
  • Uncategorized

Meet Catherine Jackson, Director of Advocacy Relations If there’s one employee that encompasses all four of Mallinckrodt’s values, it’s Catherine Jackson. As Director of Advocacy Relations in Government Affairs, Policy and Advocacy, collaboration, innovation, patient-centricity […]

Read More

Animals Tug on the Heartstrings of Mallinckrodt Volunteer Teams

  • by Gena Holthaus
  • Posted on February 4, 2019
  • Culture

*The following article is part of a series of stories highlighting how Mallinckrodt employees gave back to their communities throughout October, as part of our Global Month of Service. Animals Tug on the Heartstrings of […]

Read More

Meet Monica Minguzzi, Senior Director, Global Clinical Specialist Team

  • by Gena Holthaus
  • Posted on February 4, 2019
  • Culture

Meet Monica Minguzzi, Senior Director, Global Clinical Specialist Team Leaders like Monica Minguzzi, Senior Director of the Global Specialist team exemplifies why Mallinckrodt continues to be a place for great collaboration among colleagues, innovation in […]

Read More

Meet John Mulroy, Director, GPO/IDN Northeast

  • by Gena Holthaus
  • Posted on January 28, 2019
  • Culture

Meet John Mulroy, Director, GPO/IDN Northeast Collaboration is an important Mallinckrodt value, and one that John Mulroy, Director, GPO/IDN Northeast, carries throughout his work each day. From working with employees during sales trainings to exchanging […]

Read More

Posts navigation

Older posts
  • Guest Blog: Inflammatory Eye Disease Awareness Week

    September 27, 2021
  • June is Scleroderma Awareness Month

    June 30, 2021
  • Mallinckrodt celebrates Asian American and Pacific Islander (AAPI) Heritage Month

    May 25, 2021
  • A Message from Mallinckrodt CEO Mark Trudeau Regarding Asian American Attacks

    March 18, 2021
  • Let’s Address Racial Inequities in Healthcare by Living Our Shared Company Values

    February 23, 2021

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

Guest Blog: Inflammatory Eye Disease Awareness Week

June is Scleroderma Awareness Month

Mallinckrodt celebrates Asian American and Pacific Islander (AAPI) Heritage Month

A Message from Mallinckrodt CEO Mark Trudeau Regarding Asian American Attacks

Let’s Address Racial Inequities in Healthcare by Living Our Shared Company Values

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Areas of focus include analgesics and central nervous system drugs, and autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology. Mallinckrodt has more than 5,500 employees worldwide and a commercial presence in roughly 65 countries. The company's fiscal 2014 revenue totaled $2.54 billion.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
YouTube
LinkedIn

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.